Revvity (NYSE:RVTY) Stock Sale Revealed by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Revvity stock on September 3rd.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Revvity Trading Down 0.6%

RVTY traded down $0.92 during trading on Wednesday, hitting $154.16. 214,991 shares of the company’s stock were exchanged, compared to its average volume of 1,498,643. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $166.25. The stock has a 50 day moving average price of $134.17 and a 200 day moving average price of $112.19. The firm has a market cap of $17.20 billion, a P/E ratio of 73.61, a price-to-earnings-growth ratio of 2.83 and a beta of 1.06. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The business had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, analysts expect that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s payout ratio is 13.33%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on RVTY shares. TD Cowen upped their price target on shares of Revvity from $130.00 to $175.00 and gave the stock a “buy” rating in a research report on Tuesday. Weiss Ratings raised Revvity from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. KeyCorp boosted their price objective on Revvity from $125.00 to $165.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Royal Bank Of Canada initiated coverage on Revvity in a research report on Tuesday, September 1st. They issued a “sector perform” rating and a $135.00 target price for the company. Finally, William Blair began coverage on Revvity in a research report on Monday, October 5th. They issued an “outperform” rating for the company. Five research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Revvity presently has a consensus rating of “Hold” and a consensus target price of $124.43.

Insider Activity

In other Revvity news, insider Tajinder S. Vohra sold 7,330 shares of the firm’s stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total value of $1,032,650.40. Following the transaction, the insider owned 6,635 shares of the company’s stock, valued at $934,738.80. This trade represents a 52.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Maxwell Krakowiak sold 1,631 shares of the business’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the transaction, the insider owned 14,781 shares of the company’s stock, valued at $2,136,297.93. This represents a 9.94% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 9,130 shares of company stock valued at $1,290,745 in the last three months. Insiders own 0.85% of the company’s stock.

Hedge Funds Weigh In On Revvity

A number of institutional investors have recently added to or reduced their stakes in the company. Ascentis Independent Advisors acquired a new position in shares of Revvity in the first quarter worth about $29,000. Global Retirement Partners LLC acquired a new stake in shares of Revvity during the second quarter worth approximately $51,000. SJS Investment Consulting Inc. increased its stake in shares of Revvity by 5,210.0% in the first quarter. SJS Investment Consulting Inc. now owns 531 shares of the company’s stock worth $47,000 after buying an additional 521 shares during the last quarter. Summit Securities Group LLC boosted its stake in Revvity by 294.6% during the 1st quarter. Summit Securities Group LLC now owns 663 shares of the company’s stock valued at $58,000 after acquiring an additional 495 shares during the last quarter. Finally, Contravisory Investment Management Inc. acquired a new position in Revvity during the 1st quarter worth $66,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Revvity Company Profile

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.